Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
360 One Group CEO Bhagat Buys 1.3 Lakh Novartis India Shares for Rs 22 Crore

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

360 One Group CEO Bhagat Buys 1.3 Lakh Novartis India Shares for Rs 22 Crore

Analysed 7 Sept 2026·2 sources analysed·India·Business
360 One Group CEO Bhagat Buys 1.3 Lakh Novartis India Shares for Rs 22 CrorePreviousNext

Karan Bhagat, founder and CEO of 360 One Group and partner in Kyrush Investments, purchased 1.3 lakh shares of Novartis India from Kyrush Investments for nearly Rs 22 crore through open market transactions. The shares represented a 0.53% stake and were acquired at an average price of Rs 1,670.52 each. Novartis India also approved acquiring Pfizer's trademarks 'Minipress' and 'Minipres' for about Rs 1,250 crore. Earlier, Novartis AG agreed to sell its 70.68% stake in Novartis India to a consortium but retained its innovative medicines business in India.

Sentiment
50%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 47/100.

Outlets measured: economictimes, news18. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 7 Sept 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (50/100)

Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

news18 broke this story on 7 Sept, 02:48 pm. Other outlets followed.

7 Sept, 02:48 pm2 sources · 48 min7 Sept, 03:35 pm
  1. 1
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
SEBI Extends Deadline for Angel Funds to Meet Accredited Investor Mandate
Next →
PNGRB and EESL Partner to Deploy Smart Domestic PNG Meters Across India
news187 Sept, 02:48 pm
360 One Group CEO Bhagat buys 1.3 lakh shares of Novartis India for Rs 22 cr
  • 2
    economictimes7 Sept, 03:35 pm
    360 One Group CEO Bhagat buys 1.3 lakh shares of Novartis India for Rs 22 cr
  • Who's involved

    Institutions and figures named across source coverage.

    Corporate
    PfizerKyrush InvestmentsChrysCapitalPfizer IncNovartis India LimitedNovartis AktiengesellschaftTwo Infinity PartnersNovartis Healthcare Private LimitedNovartis AG360 One GroupWaveRise Investments

    Story context

    Category
    Business
    Location
    India
    Sources analysed
    2
    Last analysed
    7 Sept 2026
    Key entities
    NovartisLakhCroreIndian rupeeIndiaChief executive officerPfizerPharmaceutical industryBombay Stock ExchangeNew DelhiPress Trust of India